Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2023 Filed May 17, 2023 22:15 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Tax withholdingCommon Stock | 627 | $32.13 | $20,145.51 |
DisclosureSEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · nonDerivative · entry 5 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,957 F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:15 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 1,897 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · nonDerivative · entry 4 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:15 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Tax withholdingCommon Stock | 54 | $32.13 | $1,735.02 |
DisclosureSEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · nonDerivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,687 F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:15 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 163 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,741 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:15 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
GrantCommon Stock | 631 | $27.32 | $17,238.92 |
DisclosureSEC source: 0001438133-23-000084 · wf-form4_168436168222335.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,578 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c). Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:13 UTC |
Carpenter RickChief Technical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000083 · wf-form4_168436159136000.xml · derivative · entry 4 Carpenter Rick · CIK 0001513889 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,765 Underlying: Common Stock · 2,383 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). F4 · derivative.exercise_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSU granted on 5/25/2022 vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on the 15th day of the month that corresponds to the anniversary of the grant date, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:13 UTC |
Carpenter RickChief Technical Officer
|
Tax withholdingCommon Stock | 825 | $32.13 | $26,507.25 |
DisclosureSEC source: 0001438133-23-000083 · wf-form4_168436159136000.xml · nonDerivative · entry 3 Carpenter Rick · CIK 0001513889 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,675 F2 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:13 UTC |
Carpenter RickChief Technical Officer
|
Exercise / conversionCommon Stock | 2,383 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000083 · wf-form4_168436159136000.xml · nonDerivative · entry 2 Carpenter Rick · CIK 0001513889 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2023 Filed May 17, 2023 22:13 UTC |
Carpenter RickChief Technical Officer
|
GrantCommon Stock | 454 | $27.32 | $12,403.28 |
DisclosureSEC source: 0001438133-23-000083 · wf-form4_168436159136000.xml · nonDerivative · entry 1 Carpenter Rick · CIK 0001513889 · Chief Technical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,117 F1 · shares: The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan (ESPP), for the ESPP purchase period of November 16, 2022 through May 15, 2023. This transaction is also exempt under Rule 16b-3(c). Read SEC document |
| May 12, 2023 Filed May 16, 2023 23:52 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
PurchaseCommon Stock | 3,015 | $32.77 | $98,805.47 |
DisclosureSEC source: 0001438133-23-000070 · wf-form4_168428115683623.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Indirect · Leigh A. Vosseller Trust Disclosed balance after: 5,660 F1 · ownership.nature: The securities are held by the Leigh A. Vosseller Trust dated January 17, 2010, of which Leigh Vosseller is the Trustee. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:06 UTC |
Carpenter RickChief Technical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000052 · wf-form4_167908716820308.xml · derivative · entry 3 Carpenter Rick · CIK 0001513889 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,465 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSUs granted on 12/15/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSUs granted on 12/15/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:06 UTC |
Carpenter RickChief Technical Officer
|
Tax withholdingCommon Stock | 138 | $42.14 | $5,815.32 |
DisclosureSEC source: 0001438133-23-000052 · wf-form4_167908716820308.xml · nonDerivative · entry 2 Carpenter Rick · CIK 0001513889 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,663 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 21:06 UTC |
Carpenter RickChief Technical Officer
|
Exercise / conversionCommon Stock | 406 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000052 · wf-form4_167908716820308.xml · nonDerivative · entry 1 Carpenter Rick · CIK 0001513889 · Chief Technical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 23:41 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
Exercise / conversionStock Option · Derivative | 10,000 | $18.86 Strike: $18.86 | $188,600.00 |
DisclosureSEC source: 0001438133-23-000050 · wf-form4_167823247447992.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested as to fifty (50%) of the underlying shares on 6/14/2019, and the remaining shares vested in twelve (12) equal monthly installments thereafter, subject to the terms of the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 23:41 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
SaleCommon Stock | 10,000 | $41.19 | $411,884.00 |
DisclosureSEC source: 0001438133-23-000050 · wf-form4_167823247447992.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,365 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $41.16 to $41.24. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 23:41 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 10,000 | $18.86 | $188,600.00 |
DisclosureSEC source: 0001438133-23-000050 · wf-form4_167823247447992.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,365 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 18:22 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000042 · wf-form4_167771295289147.xml · derivative · entry 3 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,548 Underlying: Common Stock · 310 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 18:22 UTC |
Leal JamesSVP, Operations
|
Tax withholdingCommon Stock | 145 | $35.87 | $5,201.15 |
DisclosureSEC source: 0001438133-23-000042 · wf-form4_167771295289147.xml · nonDerivative · entry 2 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,806 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 18:22 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionCommon Stock | 310 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000042 · wf-form4_167771295289147.xml · nonDerivative · entry 1 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:57 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000038 · wf-form4_167771140016765.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,863 Underlying: Common Stock · 373 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:57 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Tax withholdingCommon Stock | 153 | $35.87 | $5,488.11 |
DisclosureSEC source: 0001438133-23-000038 · wf-form4_167771140016765.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,332 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:57 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000038 · wf-form4_167771140016765.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:41 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000048 · wf-form4_167771407609190.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,032 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:41 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 166 | $35.87 | $5,954.42 |
DisclosureSEC source: 0001438133-23-000048 · wf-form4_167771407609190.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,692 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:41 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000048 · wf-form4_167771407609190.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,858 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:36 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 819 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000046 · wf-form4_167771377846659.xml · derivative · entry 3 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,099 Underlying: Common Stock · 819 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:36 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Tax withholdingCommon Stock | 308 | $35.87 | $11,047.96 |
DisclosureSEC source: 0001438133-23-000046 · wf-form4_167771377846659.xml · nonDerivative · entry 2 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,979 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:36 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionCommon Stock | 819 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000046 · wf-form4_167771377846659.xml · nonDerivative · entry 1 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,287 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:29 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000044 · wf-form4_167771336555785.xml · derivative · entry 3 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,032 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:29 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Tax withholdingCommon Stock | 138 | $35.87 | $4,950.06 |
DisclosureSEC source: 0001438133-23-000044 · wf-form4_167771336555785.xml · nonDerivative · entry 2 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,851 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:29 UTC |
Morrison SusanEVP & Chief Admin. Officer
|
Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000044 · wf-form4_167771336555785.xml · nonDerivative · entry 1 Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:09 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000040 · wf-form4_167771216235917.xml · derivative · entry 3 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,032 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:09 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Tax withholdingCommon Stock | 154 | $35.87 | $5,523.98 |
DisclosureSEC source: 0001438133-23-000040 · wf-form4_167771216235917.xml · nonDerivative · entry 2 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,947 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 23:09 UTC |
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
|
Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000040 · wf-form4_167771216235917.xml · nonDerivative · entry 1 HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:35 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000036 · wf-form4_167771008702883.xml · derivative · entry 4 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,032 Underlying: Common Stock · 407 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: RSUs granted on 5/27/2020 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:35 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
Tax withholdingCommon Stock | 166 | $35.87 | $5,954.42 |
DisclosureSEC source: 0001438133-23-000036 · wf-form4_167771008702883.xml · nonDerivative · entry 2 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,365 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 27, 2023 Filed Mar 1, 2023 22:35 UTC |
BERGER DAVID BEVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 407 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000036 · wf-form4_167771008702883.xml · nonDerivative · entry 1 BERGER DAVID B · CIK 0001422126 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,531 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:57 UTC |
Hansen Shannon MarieSVP & General Counsel
|
Exercise / conversionRestricted Stock Unit · Derivative | 2,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000016 · wf-form4_167667099763678.xml · derivative · entry 3 Hansen Shannon Marie · CIK 0001908267 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,369 Underlying: Common Stock · 2,123 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU granted on 2/15/2022 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSU granted on 2/15/2022 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:57 UTC |
Hansen Shannon MarieSVP & General Counsel
|
Tax withholdingCommon Stock | 866 | $43.11 | $37,333.26 |
DisclosureSEC source: 0001438133-23-000016 · wf-form4_167667099763678.xml · nonDerivative · entry 2 Hansen Shannon Marie · CIK 0001908267 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,591 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 16, 2023 Filed Feb 17, 2023 21:57 UTC |
Hansen Shannon MarieSVP & General Counsel
|
Exercise / conversionCommon Stock | 2,123 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000016 · wf-form4_167667099763678.xml · nonDerivative · entry 1 Hansen Shannon Marie · CIK 0001908267 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 17:04 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionRestricted Stock Unit · Derivative | 168 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000018 · wf-form4_167667142893122.xml · derivative · entry 3 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,508 Underlying: Common Stock · 168 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 17:04 UTC |
Leal JamesSVP, Operations
|
Tax withholdingCommon Stock | 79 | $43.11 | $3,405.69 |
DisclosureSEC source: 0001438133-23-000018 · wf-form4_167667142893122.xml · nonDerivative · entry 2 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,641 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 17:04 UTC |
Leal JamesSVP, Operations
|
Exercise / conversionCommon Stock | 168 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000018 · wf-form4_167667142893122.xml · nonDerivative · entry 1 Leal James · CIK 0001866570 · SVP, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,720 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:38 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000012 · wf-form4_167666988816133.xml · derivative · entry 3 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,462 Underlying: Common Stock · 162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:38 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Tax withholdingCommon Stock | 67 | $43.11 | $2,888.37 |
DisclosureSEC source: 0001438133-23-000012 · wf-form4_167666988816133.xml · nonDerivative · entry 2 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,112 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 21:38 UTC |
Gasser Elizabeth AnneEVP, Chief Strategy Officer
|
Exercise / conversionCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000012 · wf-form4_167666988816133.xml · nonDerivative · entry 1 Gasser Elizabeth Anne · CIK 0001866283 · EVP, Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,179 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:18 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Unit · Derivative | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000024 · wf-form4_167667230513501.xml · derivative · entry 4 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,462 Underlying: Common Stock · 162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F4 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F5 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F5 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:18 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 67 | $43.11 | $2,888.37 |
DisclosureSEC source: 0001438133-23-000024 · wf-form4_167667230513501.xml · nonDerivative · entry 2 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,451 F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:18 UTC |
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 162 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000024 · wf-form4_167667230513501.xml · nonDerivative · entry 1 Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,518 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2023 Filed Feb 17, 2023 22:15 UTC |
Sheridan John FDirector · PRESIDENT & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 792 | $0.00 | $0.00 |
DisclosureSEC source: 0001438133-23-000022 · wf-form4_167667209130649.xml · derivative · entry 3 Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,132 Underlying: Common Stock · 792 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the "2013 Plan"). F3 · derivative.exercise_price: Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan. F4 · derivative.exercise_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. F4 · derivative.expiration_date: RSU granted on 5/18/2021 vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one year anniversary of the grant date, and the remaining shares shall vest in twelve(12)equal quarterly installments thereafter, subject to the terms of the 2013 Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.